Ignite Creation Date:
2025-12-25 @ 4:28 AM
Ignite Modification Date:
2025-12-26 @ 3:31 AM
Study NCT ID:
NCT01053520
Status:
COMPLETED
Last Update Posted:
2010-11-09
First Post:
2009-11-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Assess the Oral Bioavailability of a New ABT-263 Formulation in Healthy Female Subjects
Sponsor:
Abbott
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
M11-957
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Andrew Krivoshik, MD, PhD, Medical Director
Old Organization:
Abbott
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |